Many have tried to launch competing products, but the FDA had denied all but Adr... | Hacker News

Hacker News new | past | comments | ask | show | jobs | submit

login

BurningFrog on Oct 8, 2016 | parent | context | favorite | on: Mylan to Settle EpiPen Overpricing Case for $465M

Many have tried to launch competing products, but the FDA had denied all but AdrenaClick.

Thorough explanation and editorilizing here: http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-dr...

Consider applying for YC's Spring batch! Applications are open till Feb 11.
Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact